Leukemia Research
Volume 30, Issue 4 , Pages 379-383 , April 2006

Low p53 expression of acute myelocytic leukemia cells with t(8;21) chromosome abnormality: Association with low p14ARF expression

  • Masato Shikami

      Affiliations

    • Department of Internal Medicine, Division of Hematology, Aichi Medical University, 21 Karimata, Nagakute, Aichi 480-1195, Japan
    • ,
  • Hiroshi Miwa

      Affiliations

    • Department of Internal Medicine, Division of Hematology, Aichi Medical University, 21 Karimata, Nagakute, Aichi 480-1195, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 561 62 3311; fax: +81 561 63 3401.
    • ,
  • Kazuhiro Nishii

      Affiliations

    • Second Department of Internal Medicine, Mie University, School of Medicine, Tsu, Mie, Japan
    • ,
  • Taiichi Kyo

      Affiliations

    • Department of Internal Medicine, Hiroshima Red Cross Hospital, Hiroshima, Japan
    • ,
  • Isao Tanaka

      Affiliations

    • Department of Internal Medicine, Suzuka Kaisei Hospital, Suzuka, Mie, Japan
    • ,
  • Hiroshi Shiku

      Affiliations

    • Second Department of Internal Medicine, Mie University, School of Medicine, Tsu, Mie, Japan
    • ,
  • Kenkichi Kita

      Affiliations

    • Department of Internal Medicine, Tokura Hospital, Uji, Kyoto, Japan
    • ,
  • Masakazu Nitta

      Affiliations

    • Department of Internal Medicine, Division of Hematology, Aichi Medical University, 21 Karimata, Nagakute, Aichi 480-1195, Japan

Received 6 June 2005 ,Accepted 8 August 2005.

References 

  1. Rowley JD. Identification of a translocation with quinacrine fluorescence in a patient with acute leukemia. Ann Genet. 1973;16:109–112
  2. Kamada N, Okada K, Oguma N, Tanaka R, Mikami M, Uchino H. C–G translocation in acute myelocytic leukemia with low neutrophil alkaline phosphatase activity. Cancer. 1976;37:2380–2387
  3. Hagemeijer A, Garson OM, Kondo K. Translocation (8;21) (q22;q22) in acute nonlymphocytic leukaemia. Fourth International Workshop on Chromosomes in Leukemia, 1982. Cancer Genet Cytogenet. 1984;11:284–287
  4. Gao J, Erickson P, Gardiner K, Le Beau MM, Diaz MO, Patterson D, et al. Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21) (q22;q22.3) in acute myelogenous leukemia. Proc Natl Acad Sci USA. 1991;88:4882–4886
  5. Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA. 1991;88:10431–10434
  6. Erickson P, Gao J, Chang K-S, Look T, Whisenant E, Raimondi S, et al. Identification of breakpoints in t(8;21) acute myelogeous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophia segmentation gene, runt. Blood. 1992;80:1825–1831
  7. Miyoshi H, Kozu T, Shimizu N, Enomoto K, Maseki N, Kaneko Y, et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J. 1993;12:2715–2721
  8. Zhang D-E, Fujioka KI, Hetherington CJ, Shapiro LH, Chen HM, Look AT, et al. Identification of a region which directs monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1). Mol Cell Biol. 1994;14:8085–8095
  9. Nuchprayoon I, Meyers S, Scott LM, Suzow J, Hiebert S, Friedman AD. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2b/CBFb proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells. Mol Cell Biol. 1994;14:5558–5568
  10. Okuda T, van Deursen J, Hiebert SW, Grosveld G, Downing JR. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 1996;84:321–330
  11. Wang Q, Stacy T, Binder M, Marin-Padilla M, Sharpe AH, Speck NA. Distribution of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci USA. 1996;93:3444–3449
  12. Golub TR, Barker GF, Bohlander SK, Hiebert SW, Ward DC, Bray-Ward P, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukaemia. Proc Natl Acad Sci USA. 1995;92:4917–4921
  13. Mitani K, Ogawa S, Tanaka T, Miyoshi H, Kurokawa M, Mano H, et al. Generation of the AML1-EVI-1 fusion gene in the t(3;21) (q26;q22) causes blastic crisis in chronic myelocytic leukaemia. EMBO J. 1994;13:504–510
  14. Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood. 1999;93:1817–1824
  15. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet. 1999;23:166–175
  16. Preudhomme C, Warot-Loze D, Roumier C, Grardel-Duflos N, Garand R, Lai JL, et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood. 2000;96:2862–2869
  17. Shikami M, Miwa H, Nishii K, Takahashi T, Sekine T, Mahmud N, et al. Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality. Leukemia. 1999;13:358–368
  18. Linggi B, Muller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, et al. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med. 2002;8:743–750
  19. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 1992;69:1237–1245
  20. Asou H, Tashiro S, Hanamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosomal translocation. Blood. 1991;77:2031–2036
  21. Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA. 1992;89:7491–7495
  22. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, et al. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 1998;17:5001–5014
  23. Grisolano JL, O’Neal J, Cain J, Tomasson MH. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice. Proc Natl Acad Sci USA. 2003;100:9506–9511
  24. Wang YY, Zhou GB, Yin T, Chen B, Shi JY, Liang WX, et al. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA. 2005;102:1104–1109

PII: S0145-2126(05)00315-2

doi: 10.1016/j.leukres.2005.08.007

Leukemia Research
Volume 30, Issue 4 , Pages 379-383 , April 2006

Article Tools

* Image Usage & Resolution